Projections of demand trends for the Pharmaceutical Industry sub-sector going forward, from the results of Deloitte's analysis (2020) show several potential disruptions that will change the business model in the pharmaceutical industry, such as technological advancements for early detection, curative therapies, and digital therapeutics which can reduce demand for drugs, and also the use of highly sophisticated technology (such as robots, nano technology, tissue engineering) will dominate the medical world.

The transformation strategy for the Pharmaceutical Industry sub-sector that is being carried out, biotechnology development, AI and digitalization, one of which is to accelerate the search for candidate molecules and pathways for new drug synthesis. Continuous drug product development, with a focus on increasing yield, reducing production processing time, and alternative synthesis routes with cheaper intermediate materials (BBO efficiency). Development of competency standards and certification of pharmaceutical industry workers.

 

Source: bappenas.go.id